Literature DB >> 15226050

Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia.

James S Edstam1, Nyamkhuu Dulmaa, Orgil Tsendjav, Baasandorj Dambasuren, Batochir Densmaa.   

Abstract

BACKGROUND: A previous evaluation of the Mongolian hepatitis B virus (HBV) infant vaccination program showed that only 70% of rural subjects developed protective antibody levels compared to 94% of urban subjects. The difference is likely due to damaged vaccine being administered to rural infants. HBV vaccine is heat-stable, but freezing destroys immunogenicity. The current study was designed to ascertain if HBV is subject to freezing temperatures during transport to rural health centers.
METHODS: During several time periods from 2001 to 2003, HBV vaccine transported from the national vaccine store to provincial stores and from two provincial stores to rural health centers was monitored for freezing using 3M Freeze Watch indicators.
RESULTS: Of 181 provincial-to-rural transports, 19% (95% CI 13-25%) resulted in freezing. One of 59 or 1.6% (95% CI 0-5.6%) of national-to-provincial store transports indicated freezing. In the second half of each substudy, freezing events diminished. Duration of transport was associated with freezing.
CONCLUSION: Identification of freezing temperatures during provincial-to-rural vaccine transport provides evidence that HBV vaccine is being damaged. This is the likely cause of the poor vaccine response in the Mongolian countryside. The authors speculate that packing vaccines for transport with ice taken directly from storage deep freezes at -20 degrees C is the cause of the freezing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226050     DOI: 10.1016/j.ypmed.2004.01.029

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  12 in total

1.  A freeze-stable formulation for DTwP and DTaP vaccines.

Authors:  Honggang Xue; Bangling Yang; Debra D Kristensen; Dexiang Chen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Authors:  Manoj V Murhekar; Srihari Dutta; Ambujam Nair Kapoor; Sailaja Bitragunta; Raja Dodum; Pramit Ghosh; Karumanagounder Kolanda Swamy; Kalyanranjan Mukhopadhyay; Somorjit Ningombam; Kamlesh Parmar; Devegowda Ravishankar; Balraj Singh; Varsha Singh; Rajesh Sisodiya; Ramaratnam Subramanian; Tana Takum
Journal:  Bull World Health Organ       Date:  2013-09-09       Impact factor: 9.408

3.  Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China.

Authors:  Qian Ren; Hongyan Xiong; Yafei Li; Rufu Xu; Caizhong Zhu
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

4.  Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey.

Authors:  Dambadarjaa Davaalkham; Toshiyuki Ojima; Steven Wiersma; Tserenkhuu Lkhagvasuren; Pagvajav Nymadawa; Ritei Uehara; Makoto Watanabe; Izumi Oki; Yosikazu Nakamura
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

5.  The effect of cool water pack preparation on vaccine vial temperatures in refrigerators.

Authors:  Geneva Goldwood; Steven Diesburg
Journal:  Vaccine       Date:  2017-11-22       Impact factor: 3.641

6.  Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.

Authors:  Masataro Norizuki; Tomomi Kitamura; Kenichi Komada; Masaya Sugiyama; Masashi Mizokami; Anonh Xeuatvongsa; Vilasak Som-Oulay; Phengta Vongphrachanh; Munehito Machida; Koji Wada; Koji Ishii; Tomoko Kiyohara; Takaji Wakita; Masahiko Hachiya
Journal:  BMC Infect Dis       Date:  2019-06-10       Impact factor: 3.090

7.  Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51.

Authors:  Rashi Yadav; Lukai Zhai; Nitesh K Kunda; Pavan Muttil; Ebenezer Tumban
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

Review 8.  Tools and approaches to ensure quality of vaccines throughout the cold chain.

Authors:  Umit Kartoglu; Julie Milstien
Journal:  Expert Rev Vaccines       Date:  2014-05-28       Impact factor: 5.217

9.  Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature.

Authors:  Julianne Peabody; Pavan Muttil; Bryce Chackerian; Ebenezer Tumban
Journal:  Papillomavirus Res       Date:  2017-04-08

10.  Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges.

Authors:  Dambadarjaa Davaalkham; Toshiyuki Ojima; Ritei Uehara; Makoto Watanabe; Izumi Oki; Steven Wiersma; Pagvajav Nymadawa; Yosikazu Nakamura
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.